-
Ionophore Toxicity in Animals: Molecular Insights
2026-09-29
This review integrates clinical observations with molecular mechanisms to explain why polyether ionophore toxicity is concentrated in cardiac and skeletal muscle and varies with dose, species, and age. Its discussion of ion concentration dysregulation, oxidative phosphorylation, and tiamulin–ionophore interactions provides a useful framework for veterinary safety assessment and future drug-repurposing research.
-
Z-VAD-FMK: A Mechanistic Map of Cell Death
2026-09-29
Z-VAD-FMK is more than a broad apoptosis blocker: it is a causal tool for separating caspase-dependent apoptosis from pyroptotic execution. This guide integrates product chemistry with the NU6300–GSDMD study to improve assay design, interpretation, and cell-death pathway research.
-
Escitalopram: From SERT Mechanism to Translation
2026-09-28
Escitalopram is more than a familiar SSRI name: it is a selective, stereochemically defined tool for interrogating serotonin transporter biology and translational neuropsychiatry. This article connects molecular selectivity with assay design, endpoint separation, and clinical interpretation, using the ziprasidone augmentation literature to show why depression and anxiety outcomes should not be treated as interchangeable.
-
Magneto-Piezoelectric Scaffolds for Infectious Bone Repair
2026-09-28
This ACS Nano study combines magnetic biofilm disruption with ultrasound-responsive immune modulation in a 3D-printed scaffold for infectious bone defects. Its findings identify Icam1+ macrophage oxidative phosphorylation, linked to JAK2-STAT3 signaling, as a potential bridge between infection control and bone regeneration.
-
FLCN Variants and mRNA Rescue in Birt-Hogg-Dubé
2026-09-27
A study of two Chinese families with Birt-Hogg-Dubé syndrome reports a novel FLCN nonsense variant, p.Q44*, and functional evidence supporting p.W376R pathogenicity. In HEK293T cells, synthetic FLCN mRNA restored folliculin expression and reduced abnormal mTORC1 signaling, offering a preclinical proof of concept—not a clinical treatment—for mRNA-based functional rescue.
-
Deuterium-Labeled Degarelix: A 13-Step Synthesis
2026-09-26
The study describes a 13-step route to deuterium-labeled degarelix acetate, using D₂O/D₃PO₄ to introduce seven deuterium atoms into a naphthyl-containing amino acid building block. The resulting labeled antagonist was obtained in 14% overall yield, providing a practical synthetic basis for preparing an internal standard for pharmacokinetic and ADME studies.
-
Zwitterionic Lipids Improve mRNA Cancer Vaccines
2026-09-25
Zhao and colleagues designed membrane-destabilizing zwitterionic lipids that switch charge in mildly acidic endosomes, improving mRNA expression and reducing local reactogenicity in mouse studies. The findings suggest a formulation strategy for balancing endosomal escape and tolerability, while leaving clinical translation and the performance of other lipid excipients to be tested.
-
High-Throughput Microscopy for Fractional Killing
2026-09-25
Inde and colleagues describe a time-resolved microscopy protocol for measuring drug-induced fractional killing, enabling parallel comparisons across hundreds of experimental conditions. By separately tracking live and dead cells, the approach helps researchers distinguish population-level survival from variable cell-death responses to pathway inhibitors.
-
Entecavir Workflows for HBV Research
2026-09-24
Use Entecavir (BMS200475) to build mechanistically focused HBV replication assays, from nanomolar dose–response testing to resistance-aware comparisons. This workflow guide connects product handling, viral-DNA endpoints, and cccDNA interpretation while separating established evidence from practical starting conditions.
-
Sex Differences in Angiotensin II Hypertension in Mice
2026-09-24
Xue and colleagues used telemetry in conscious mice to show that chronic angiotensin II infusion raised blood pressure more in males than females, while gonadectomy shifted the response in opposite directions by sex. Their findings connect this difference with altered baroreflex and sympathetic contributions, and show why sex and autonomic measurements matter when interpreting experimental hypertension.
-
Electroporation for CRISPR Editing in Mouse Zygotes
2026-09-23
Hashimoto and Takemoto optimized electroporation to deliver CRISPR/Cas9 RNAs into mouse zygotes without removing the zona pellucida, offering an alternative to labor-intensive microinjection. Their work established pulse conditions that balanced mRNA delivery with embryo survival and demonstrated use of the approach for genome editing, including ssODN-mediated knock-in.
-
High-Throughput BBB Modeling with Lysosomal Correction
2026-09-23
The reference study develops a scalable blood-brain barrier surrogate by pairing LLC-PK1-MOCK and LLC-PK1-MDR1 cells with a correction step for lysosomal trapping. Its permeability, transporter, and recovery measurements improve interpretation of brain penetration and support earlier prioritization of CNS drug candidates.
-
M344 Histone Deacetylase Inhibitor Workflows
2026-09-22
M344 links chromatin remodeling to practical cancer-cell assays, including proliferation, differentiation, radiation-response, and apoptosis workflows. This guide shows how to select exposure conditions, control solvent and toxicity, and translate comparative evidence into more reproducible experiments.
-
H-151 Links STING Inhibition to Ferroptosis Control
2026-09-22
The reference study shows that H-151 suppresses ferroptosis through radical-trapping antioxidant activity that is independent of STING inhibition. By reducing both inflammatory STING signaling and lipid peroxidation, H-151 protected against renal ischemia-reperfusion injury in mice, suggesting a dual-pathway strategy for studying this complex tissue injury.
-
BHQ: A SERCA Lens on Calcium-to-Mobility Biology
2026-09-21
2,5-di-tert-butylbenzene-1,4-diol (BHQ) is more than a calcium-store perturbant: it is a mechanistic tool for connecting SERCA inhibition, ER stress, calcium signaling, and hematopoietic stem cell mobilization. This thought-leadership analysis translates recent HSC evidence into practical experimental strategy while defining the limits of cross-domain interpretation.